To study the role of triglyceride glucose index (TyG Index) as a novel biomarker in patients of type 2 diabetes mellitus (T2DM) developing acute coronary syndrome (ACS)
The TyG index, derived from fasting triglycerides and blood glucose, is a simple and cost-effective marker for insulin resistance (IR) and cardiovascular risks. It is comparable to other markers in predicting conditions such as coronary artery disease (CAD) and atherosclerosis and can be incorporated into the routine clinical evaluation of T2DM patients to predict the risk of ACS, which remains a leading cause of cardiovascular morbidity and mortality in T2DM.
Authors
- Gyanendra Kumar Sonkar (ORCID: https://orcid.org/0000-0002-0813-5466)
- Amit Kumar (ORCID: https://orcid.org/0000-0002-0531-328X)
- Vishwa Deepak Tiwari
- Vivek Bhosale (ORCID: https://orcid.org/0000-0002-2729-266X)
- Wahid Ali (ORCID: https://orcid.org/0000-0002-0474-6200)
- Gaurav Chaudhary (ORCID: https://orcid.org/0000-0002-5428-5094)
- Satyendra Kumar Sonkar (ORCID: https://orcid.org/0000-0002-6350-9299)
- Mahak Lamba (ORCID: https://orcid.org/0009-0008-9403-9331)
- Prateek Chaudhary
Institutions
- Central Drug Research Institute (IN)
- King George's Medical University (IN)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2025-03-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_1488_24
- Citations
- 1
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.39